Cannabinoides…
577
59. Alexander, A.; Smith, P. F.; Rosengren, R. J. Cannabinoids in the treatment of cancer. Cancer
Lett, 285 (1), 6-‐12 (2009).
60. Engels, F. K.; De Jong, F. A.; Mathijssen, R. H.; Erkens J. A.; Herings, R. M.; Verweij, J.
Medicinal cannabis in oncology. Eur J Cancer, 43 (18), 2638-‐2644 (2007).
61. Brown, I.; Cascio, M. G.; Rotondo, D.; Pertwee, R. G.; Heys, S. D.; Wahle, K. W. Cannabinoids
and omega-‐3/6 endocannabinoids as cell death and anticancer modulators. Prog Lipid
Res, 52 (1), 80-‐109 (2013).
62. Baker, D.; Pryce, G.; Giovannoni, G. Thompson, A. J. The therapeutic potential of cannabis.
Lancet Neurol, 2 (5):291-‐298 (2003).
63. Di Marzo, V.; Piscitelli, F.; Mechoulam, R. Cannabinoids and endocannabinoids in metabolic
disorders with focus on diabetes. Handb Exp Pharmacol, (203), 75-‐104 (2011).
64. Horváth, B.; Mukhopadhyay, P.; Haskó, G.; Pacher, P.The endocannabinoid system and
plant-‐derived cannabinoids in diabetes and diabetic complications. Am J Pathol., 180 (2),
432-‐442 (2012).
65. Pinar-‐Sueiro, S.; Rodríguez-‐Puertas, R.; Vecino, E. Aplicaciones de los cannabinoides en
glaucoma. Arch Soc Esp Oftalmol, 86 (1), 16-‐23 (2011).
66. Tomida, I.; Pertwee, R. G.; Azuara-‐Blanco, A. Cannabinoids and glaucoma. Br J Ophthalmol,
88 (5), 708-‐713 (2004).
67. Abboud, R. T.; Sanders, H. D. Effect of oral administration of delta-‐tetrahydrocannabinol on
airway mechanics in normal and asthmatic subjects. Chest, 70 (4), 480-‐485 (1976).
68. Guimarães, F. S.; Chiaretti, T. M.; Graeff, F. G.; Zuardi, A. W. Antianxiety effect of cannabidiol
in the elevated plus-‐maze. Psychopharmacology, 100 (4), 558-‐559 (1990).
69. Guimarães, F. S.; De Aguiar, J. C.; Mechoulam, R.; Breuer, A. Anxiolytic effect of cannabidiol
derivatives in the elevated plus-‐maze. Gen Pharmacol, 25 (1) 161-‐164 (1994).
70. Hall, W. The adverse health effects of cannabis use: What are they, and what are their
implications for policy?. Int J Drug Policy., 20 (6), 458-‐466 (2009).
71. Danovitch, I.; Gorelick, D. A. State of the art treatments for cannabis dependence. Psychiatr
Clin North Am, 35 (2), 309-‐326 (2012).
72. McPartland, J. M.; Russo, E. B. Cannabis and cannabis extracts: greater than the sum of their
parts?. J. Cannabis Ther., 1, (3-‐4), 103-‐132 (2001).
73. Russo, E. B.; McPartland, J. M. Cannabis is more than simply D9-‐tetrahydrocannabinol.
Psychopharmacology, 165 (4), 431–432 (2003).
74. Hall, W.; Christie, M.; Currow, D. Cannabinoids and cancer: causation, remediation,
and palliation. Lancet Oncol, 6 (1), 35-‐42 (2005).
